Influenza virus, a negative-stranded RNA virus that causes severe illness in humans and animals, stimulates the inflammasome through the Nod-like receptor NLRP3. However, the mechanism by which influenza virus activates the NLRP3 inflammasome is unknown. Here we show that the influenza virus M2 protein, a proton-selective ion channel important in viral pathogenesis, stimulates the NLRP3 inflammasome pathway. M2 channel activity was required for the activation of inflammasomes by influenza and was sufficient to activate inflammasomes in primed macrophages and dendritic cells. M2-induced activation of inflammasomes required its localization to the Golgi apparatus and was dependent on the pH gradient. Our results show a mechanism by which influenza virus infection activates inflammasomes and identify the sensing of disturbances in intracellular ionic concentrations as a previously unknown pathogen-recognition pathway.
A r t i c l e s
Influenza virus is responsible for annual epidemics that cause severe illness in ~5 million people worldwide. Evidence has shown that influenza infection engages the NLRP3 inflammasome complex in dendritic cells and macrophages [1] [2] [3] [4] . NLRP3 forms a multiprotein complex with the adaptor protein ASC (pycard) and caspase-1, which leads to the catalytic cleavage of the immature ('pro') forms of interleukin 1β (IL-1β), IL-18 and IL-33. Inflammasome-mediated cytokine release via NLRP3 requires two signals 5 : signal 1 is induced by Toll-like receptor (TLR) stimulation and leads to the synthesis of pro-IL-1β, pro-IL-18 and pro-IL-33; signal 2, triggered by agents that can cause membrane perturbations, specifically potassium efflux, induces activation of caspase-1 and cleavage of pro-IL-1β, pro-IL-18 and pro-IL-33. Wellknown examples of signal 2 include pore-forming microbial toxins, maitotoxin, aerolysin and nigericin, which activate NLRP3 inflammasomes by allowing efflux of potassium from the cytosol [5] [6] [7] . In addition, lysosomal membrane damage caused by phagocytosis of crystals such as asbestos, silica and aluminum salt triggers NLRP3 activation 8, 9 .
The mechanism by which viral infection results in activation of the NLRP3 inflammasome is unclear. Infection with either DNA or RNA viruses results in NLRP3-dependent inflammasome activation [1] [2] [3] [4] 10, 11 , and studies have identified AIM2 as a sensor of double-stranded DNA (dsDNA) that is able to stimulate inflammasomes [12] [13] [14] [15] . AIM2 consists of a HIN-200 domain, which binds to DNA, and a pyrin domain, which associates with ASC to activate both the transcription factor NF-κB and caspase-1. However, AIM2-induced activation is NLRP3 independent 12, 13 . In contrast to the mechanisms known for dsDNA viruses, the mechanism by which influenza virus, a negative-stranded RNA virus, triggers activation of the NLRP3 inflammasome is unknown. Here we examine the cellular mechanism by which influenza virus infection elicits the NLRP3 inflammasome.
RESULTS

Influenza subtypes induce potent inflammasome activation
To determine whether inflammasome activation is generally induced by viral infection, we compared the ability of several viruses to trigger inflammasome activation by measuring IL-1β secretion from infected bone marrow-derived macrophages (BMMs; Fig. 1a) . All influenza virus strains tested, including influenza A and B types, induced robust release of IL-1β from BMMs (Fig. 1a) . The induction of IL-1β by influenza was also dependent on NLRP3, ASC and caspase-1 ( Supplementary Fig. 1a,b) , as demonstrated before [1] [2] [3] [4] . In addition, IL-1β secretion induced by influenza infection ( Supplementary  Fig. 1a,b) , but not that induced by dsDNA ( Supplementary Fig. 1c) , was NLRP3 dependent. In contrast, at the same multiplicity of infection (MOI), two other single-stranded RNA viruses, Sendai virus (paramyxovirus) and vesicular stomatitis virus (rhabdovirus; data not shown), as well as the dsDNA virus herpes simplex virus type 2 (HSV-2), activated inflammasomes to a much smaller extent, despite robust stimulation of inflammasome-independent cytokines, such as IL-6 (Fig. 1a) and tumor necrosis factor (TNF; Fig. 1b) . These data indicate that influenza virus infection alone is able to activate both signal 1 and signal 2 in unprimed BMMs or dendritic cells (DCs). In addition, these findings suggest that inflammasome activation is mediated by a specific feature associated with influenza virus infection that is not common to other single-stranded RNA viruses.
Influenza virus activates pro-IL-1 synthesis via TLR7
To determine the nature of the signal 1 induced by influenza infection, we examined the two known innate recognition pathways for influenza virus. Influenza genomic RNA is recognized in the endosome by TLR7 (refs. 16,17) , whereas the viral RNA receptor RIG-I recognizes the 5′ triphosophate end of viral RNA in the cytosol 18, 19 . Analysis of the release of IL-1β from bone marrow-derived DCs (BMDCs) lacking TLR7 or MAVS (the adaptor of RIG-I signaling) showed that TLR7 signaling was required for the transcription of pro-IL-1β ( Fig. 2a) and release of mature IL-1β after influenza infection ( Fig. 2b) but MAVS was not. Next, we tested whether influenza virus RNA alone might be uniquely able to stimulate both signal 1 and signal 2 after infection. We compared the ability of influenza genomic RNA and, as a control, synthetic dsRNA (poly(I:C)) to stimulate the release of IL-1β (Fig. 2) . Unlike infection with live virus, transfection with influenza virus RNA in complex with liposomes, with or without the 5′-triphosphate (viral RNA treated with calf intestinal phosphatase), although it induced robust expression of type I interferon, failed to stimulate secretion of IL-1β from BMMs. In addition, poly(I:C) also failed to elicit inflammasome activation in the absence of ATP, as reported before 11 . The failure of the transfected RNA to induce IL-1β secretion (Fig. 2c) was not due to its inability to induce the synthesis of pro-IL-1β protein but was instead due to the lack of IL-1β processing by caspase-1 in the cytosol (Fig. 2d) . These data indicate that viral RNA alone is insufficient to trigger robust activation of the NLRP3 inflammasome and that signal 2 is probably derived from a virus-encoded protein.
Activity of the M2 ion channel induces inflammasome activation
To investigate how influenza virus infection stimulates signal 2 for inflammasome activation, we focused on a feature shared by other known NLRP3 agonists: the ability to perturb cellular membranes. Influenza virus encodes the proton-specific ion channel M2, which has a key role in both fusion during viral entry and the synthesis of new virions 20 . M2 acts in at least two subcellular locations. In acidifying endosomes that contain the invading virions, M2 serves to import hydrogen ions (H + ) into the virions and helps to release viral ribonucleocapsid into the cytosol 21 . In the acidic trans-Golgi network, M2 has a key role in transporting H + out of the lumen, which leads to neutralization of the trans-Golgi network pH and prevents hemagglutinin from becoming fusogenic 22 . Because M2 can alter ionic concentrations in intracellular compartments, we hypothesized that it may serve as signal 2 during inflammasome triggering. To test whether M2 ion-channel activity is needed to elicit influenza-induced inflammasome stimulation, we infected BMMs and BMDCs with influenza virus lacking amino acids 29-31 from the transmembrane region of the M2 protein (M2del29-31) 21 . These amino acids are required for M2 to transport H + (ref. 23 ). However, this deletion still allows expression of the mutant M2 in the cell 23 . Notably, the M2del29-31 mutant influenza virus completely failed to stimulate inflammasome activation or the release of IL-1β or IL-18 from BMMs ( Supplementary  Fig. 2) or BMDCs (Fig. 3a) . In addition, we detected mature caspase-1 only in the supernatants of cells infected with wild-type influenza virus, not those infected with M2del29-31 mutant virus (Fig. 3b) . The M2del29-31 mutant virus has been reported to have either similar 24 or lower 21 replicative capacity in vitro. A trivial explanation for our results is that M2del29-31 failed to infect the target cells. However, three sets of evidence ruled out this possibility. First, the extent of infection by the M2del29-31 mutant virus was similar to that of wildtype virus (Supplementary Fig. 3a) . Second, cells infected with the M2del29-31 mutant virus expressed amounts of pro-IL-1β mRNA (Fig. 3c) and protein ( Fig. 3d ) similar to those expressed by cells infected with wild-type virus. Third, the M2del29-31 mutant virus induced the production of non-inflammasome-dependent cytokines such as TNF and IL-12 by infected BMDCs in amounts similar to those induced by wild-type virus (Fig. 3a) . To provide definitive evidence that the loss of M2 ion-channel activity was responsible for the A r t i c l e s failure of the M2del29-31 virus to activate inflammasomes, we did a complementation experiment. Intact M2 channel expressed from a lentivirus was able to completely restore the ability of M2del29-31 virus to trigger inflammasomes (Fig. 4) . In addition, the influenza A M2 channel blocker amantadine inhibited the release of IL-1β from BMMs induced by influenza A but not that induced by influenza B (Supplementary Fig. 3b-e) . Finally, virus treated with ultraviolet irradiation, which is able to attach, fuse with and enter with intact M2 channel but lacks the ability to produce M2 de novo, failed to trigger IL-1β secretion 1 . These data collectively indicate that channel activity of newly synthesized M2 is required for the stimulation of NLRP3 inflammasomes.
M2 is sufficient to trigger inflammasome activation
Next, we assessed whether M2 is sufficient to trigger the NLRP3 inflammasome. We stimulated BMMs and BMDCs with lipopolysaccharide (LPS; signal 1) and transduced them with a lentivirus expressing M2 protein derived from influenza strain A/PR/8/34 (subtype H1N1; Fig. 5a ). Both IL-1β and IL-18 were specifically released from LPS-primed cells transduced with M2-expressing lentivirus constructs but from those transduced with control (green fluorescent protein (GFP)) lentivirus constructs (Fig. 5b,c) . In unprimed BMMs, M2 expression alone was not sufficient to trigger IL-1β release (Supplementary Fig. 4a-c) . In addition, we compared inflammasome stimulation after ectopic expression of lentivirus-driven M2 from the highly pathogenic influenza virus strains A/Viet Nam/1194/2004 (subtype H5N1) and 1918 Spanish flu A/Brevig Mission/1/1918 (H1N1; Fig. 5a ) to determine whether the inflammation induced by these subtypes 25 could be explained in part by the ability of the respective M2 protein to trigger inflammasome activation. M2 from all three viral strains elicited similar inflammasome activation (Fig. 5b,c) . In contrast, TNF and pro-IL-1β were produced in cells under all conditions in which LPS was present, regardless of M2 expression (Fig. 5b,c) , which indicated a specific effect of M2 on inflammasome activation. Next, we sought to determine if M2 could stimulate inflammasomes in the presence of other viral triggers of signal 1. Similar to results obtained with BMMs (Fig. 1a) , Sendai virus and HSV-2 induced marginal amounts of inflammasome activation in BMDCs (Fig. 6) . However, M2 expression significantly potentiated NLRP3-dependent inflammasome activation in cells infected with Sendai virus or HSV-2 ( Fig. 6 and Supplementary Fig. 4d,e) . These data provide evidence that M2 is sufficient to trigger signal 2 for activation of the NLRP3 inflammasome and indicate that it was the expression of M2 that was responsible for inflammasome activation by influenza but not by the other viruses tested (Fig. 1) .
M2-mediated perturbation of ionic concentrations
We next investigated the mechanism by which M2 triggers NLRP3 inflammasomes. We first tested the role of previously identified factors that potentiate activation of the NLRP3 inflammasome 26 . We found that treatment of cells with a high extracellular concentration of KCl, despite having little effect on M2 expression (Supplementary Fig. 5c ) or viral replication (Supplementary Fig. 5j ), prevented M2-dependent production of IL-1β (Supplementary Fig. 5a,b) . In addition, inhibition of IL-1β production by KCl was not due to general toxicity, as demonstrated by normal secretion of IL-1β after dsDNA-dependent inflammasome activation (Supplementary Fig. 5d ). We also found a partial requirement for the receptor P2X7 in the inflammasome activation induced by influenza (Supplementary Fig. 5e ) but not that induced by dsDNA (Supplementary Fig. 5f ). ATP ( Supplementary  Fig. 5g,h ) and reactive oxygen species (Supplementary Fig. 5i ) also seemed to have a role in influenza-and M2-induced activation of the inflammasome. However, only picomolar concentrations of ATP were secreted from BMDCs infected with wild-type or M2del29-31 influenza (Supplementary Fig. 5h ), which alone were not sufficient to trigger K + efflux 27 and NLRP3 inflammasomes.
Next, we examined whether the proton specificity of the M2 channel is required for NLRP3 activation. For this, we transduced cells with lentivirus encoding M2 protein with substitution of glycine for histidine at position 37 (H37G). The proton selectivity of M2 is lost when His37 of the transmembrane domain is substituted, which enables the transport of other cations (Na + and K + ) 28 . The H37G M2 mutant induced almost twofold more secretion of IL-1β from Figs. 4 and 6) , which indicated that in addition to imbalances in the concentration of H + , disturbances in the concentrations of other cationic species act as a trigger for inflammasome activation. Similarly, lentiviral complementation of the H37G M2 mutant in BMMs or BMDCs infected with the Mdel29-31 mutant influenza virus resulted in twofold more inflammasome activation than did wild-type M2 (Supplementary Fig. 6 ). Therefore, these data indicate that many of the pathways common to other NLRP3 stimuli are required for M2 to elicit inflammasomes. Although proton selectivity of the channel is not required, the direct mechanism by which the M2 ion channel induces NRLP3 inflammasome activation still remained unclear.
LPS-or poly(I:C)-activated BMMs and BMDCs than did wild-type M2 (Supplementary
To address the intracellular mechanism by which M2 triggers inflammasome activation, we undertook three separate approaches. First, as M2 is a pH-gated H + channel that neutralizes the pH of the trans-Golgi network 22 , we tested whether we could mimic the activity of M2 with monensin, a Na + -H + antiporter that exports H + from the trans-Golgi network 29 . Treatment with monensin enabled inflammasome activation in BMMs treated with LPS or infected with Sendai virus or HSV-2 (Fig. 7a) . In addition, influenza-induced release of IL-1β was enhanced by treatment with monensin. Mature IL-1β undergoes noncanonical export independent of the endoplasmic reticulum or Golgi 6 . Because monensin effectively blocks the transport of proteins through the classical secretory pathway, its ability to enhance IL-1β secretion could be in some way related to its ability to alter the trafficking and secretion of proteins. Thus, we tested the effect of brefeldin A, another inhibitor of classical secretory pathway, on IL-1β secretion after influenza infection. In contrast to the treatment of cells with monensin, treatment with brefeldin A, which causes collapse of the Golgi into the endoplasmic reticulum and the accumulation of proteins in the endoplasmic reticulum 30 , blocked inflammasome activation by influenza virus but not by LPS plus ATP (Fig. 7b) . Intracellular-localization analysis of M2 showed that treatment with monensin indeed restricted M2 almost exclusively to the Golgi compartment, whereas treatment with brefeldin A resulted in the collapse of the Golgi into the endoplasmic reticulum 30 (Fig. 7c) and expression of M2 in the endoplasmic reticulum (Supplementary Fig. 7) . In untreated cells, M2 trafficked from mostly the Golgi apparatus (7 h after infection) to the plasma membrane within 12 h of infection ( Fig. 7c and  Supplementary Fig. 8) . Cells left untreated with or treated with monensin or brefeldin A expressed similar amounts of M2 protein intracellularly (Supplementary Fig. 8 ). Thus, these data indicate that the localization of M2 to the Golgi, but not its localization to the endoplasmic reticulum, correlates with inflammasome activation and that a general blockade of protein transport in the classical secretory pathway does not account for the ability of monensin to elicit inflammasome activation. Second, as M2 is localized to both the Golgi and the plasma membrane, it remained unclear which of these locations was important for activating inflammasomes. Thus, to examine whether plasma membrane-localized M2 was able to activate the NLRP3 inflammasome, we took advantage of the fact that M2 localizes to the plasma membrane in influenza-infected cells after 12 h of infection ( Fig. 7c and Supplementary Fig. 8 ). 
A r t i c l e s
The M2 channel conducts protons only when the pH of the medium bathing the amino-terminal ectodomain is lowered below 7 (ref. 20) . We used this feature of the M2 channel to probe the site of M2 activity required for inflammasome activation. Thus, we reasoned that if M2 at the plasma membrane activates inflammasomes, incubating cells at a pH below 7 would elicit robust inflammasome activity by facilitating H + transport into the cytosol. Conversely, an extracellular pH above 7 should block the ion-channel activity and thus prevent inflammasome activation. However, in both BMMs and DCs, altering the extracellular pH to either a lower or higher value had no effect on inflammasome activation (Fig. 8a) . These data indicate that plasma membrane M2 does not mediate inflammasome activation. Finally, to determine whether M2-induced activation of inflammasomes requires an acidified pH in the Golgi, we used the E5 molecule from bovine papillomavirus, which specifically neutralizes the trans-Golgi network without affecting other intracellular compartments by binding to and inhibiting vacuolar H + ATPase 31 . We first transduced cells with retrovirus encoding E5 protein or its inactive mutant E5 Q17G, which is unable to alkalinize the Golgi, and subsequently infected the cells with various doses of influenza virus. These analyses showed that only the wild-type E5, not the mutant E5 Q17G, blocked the activity of influenza-induced inflammasomes (Fig. 8b) without affecting the secretion of IL-6 and TNF or inflammasome activation induced by LPS plus ATP (Supplementary Fig. 9 ). Thus, these data indicated that acidification of the Golgi apparatus is a prerequisite for influenza-induced activation of inflammasomes. Together our data show that M2 channel-induced activation of inflammasomes correlates with its Golgi localization but not its endoplasmic reticulum localization, is independent of its plasma membrane localization, and requires an acidified Golgi compartment (Supplementary Fig. 10 ).
DISCUSSION
Our findings here have identified a previously unknown mechanism by which inflammasomes are triggered through detection of the activity of a virus-encoded ion channel. Specifically, influenza infection activates signal 1 through stimulation of macrophages and DCs via TLR7, which leads to synthesis of pro-IL-1β and pro-IL-18. After infection, virus-encoded M2 is expressed in the secretory The enhanced capacity of the H37G M2 channel to elicit inflammasome activation may be related to its potential ability to export K + in exchange for Na + at the plasma membrane, as K + efflux is a wellknown activator of NLRP3 inflammasomes 7, 32 . On the basis of the requirement for K + efflux and partial requirements for ATP, P2X7 and reactive oxygen species in influenza-induced activation of inflammasomes, we speculate that dysregulated ionic concentrations in the Golgi in some way lead to the activation of plasma membrane channels, which results in K + efflux and activation of the NLRP3 inflammasome complex. In addition, it is also possible that ATP released from influenza-infected dying cells 33 amplifies the inflammasome activation. Our data have demonstrated that viral RNA is insufficient to trigger robust activation of the NLRP3 inflammasome. Thus, neither transfection of viral RNA or poly(I:C) into DCs nor treatment of DCs with influenza virus inactivated by ultraviolet irradiation 1 elicited substantial IL-1β secretion. Instead, viral infection and activity of the M2 channel was needed for full triggering of NLRP3 inflammasome activation. Although some release of IL-1β is induced by RNA agonists alone 3, 4 , our direct comparison showed that the amount secreted by cells infected with influenza virus was considerably higher. These data are consistent with a published report showing that treatment with poly(I:C) or infection with RNA viruses (reovirus and vesicular stomatitis virus) fails to elicit inflammasome activation 11 . Our data have also demonstrated that TLR7, but not MAVS, is required for transcriptional activation of IL-1β. However, a published report indicates that recognition of cytosolic RNA by RIG-I can stimulate both signal 1 (via MAVS, CARD9) and signal 2 (via ASC independent of MAVS, CARD9 and NLRP3) 34 . Therefore, cells infected with RNA viruses could use distinct molecular complexes, NLRP3-ASC and RIG-I-ASC, to trigger inflammasome activation.
In infected cells, M2 is expressed in the endoplasmic reticulum and Golgi and then at the plasma membrane in a sequential manner. We have provided several lines of evidence that suggest that the relevant location from which M2 triggers inflammasome activation is probably not the plasma membrane or the endoplasmic reticulum, as acidification of extracellular space or retention of M2 in the endoplasmic reticulum by brefeldin A was not associated with inflammasome activation. Instead, acidification of the Golgi was a prerequisite, as shown by the ability of bovine papillomavirus E5 protein to block the activity of influenza-induced inflammasomes. Limited by a lack of technology, we were unable to directly address whether ionic imbalance in the Golgi compartment was sufficient to trigger M2-mediated inflammasome activation. However, these data collectively suggested that sensing of cellular stress imposed by imbalances in ionic concentrations in intracellular vesicles could serve as a pathogen-recognition pathway.
Our data have also shown that in addition to the more drastic disruption of membranes by pore-forming toxins or membrane rupture, pathogen-encoded ion channels signal inflammasome activation. As ion channels are used by other viruses (notably by human immunodeficiency virus, which encodes the protein Vpu, whose transmembrane domain acts as potassium channel 35 to enhance viral particle release 36 ), we speculate that the ion-channel activity of many viral and bacterial pathogens is sensed by eukaryotic cells to trigger the NLR inflammasomes. Such a model represents a previously unappreciated mechanism by which the innate immune system senses critical pathogen-catalyzed cellular stress pathways to facilitate viral clearance, with important implications for both viral evolution and host-pathogen interactions. Future studies that elucidate the relevance of other microbial ion channels in the activation of innate receptors will aid the ability to design effective interventions and treatments for the prevention of infectious diseases.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
